These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 2783549)

  • 21. Mechanisms of lysis by cytotoxic T lymphocyte clones. Lytic activity and gene expression in cloned antigen-specific CD4+ and CD8+ T lymphocytes.
    Lancki DW; Hsieh CS; Fitch FW
    J Immunol; 1991 May; 146(9):3242-9. PubMed ID: 1673149
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Use of the 5'-flanking region of the mouse perforin gene to express human Fc gamma receptor I in cytotoxic T lymphocytes.
    Smyth MJ; Kershaw MH; Hulett MD; McKenzie IF; Trapani JA
    J Leukoc Biol; 1994 Apr; 55(4):514-22. PubMed ID: 8145022
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Dissociation of membrane binding and lytic activities of the lymphocyte pore-forming protein (perforin).
    Young JD; Damiano A; DiNome MA; Leong LG; Cohn ZA
    J Exp Med; 1987 May; 165(5):1371-82. PubMed ID: 3494808
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Full-length cloning and 3'-terminal portion expression of human perforin cDNA.
    Li F; Zhou X; Qin W; Wu J
    Clin Chim Acta; 2001 Nov; 313(1-2):125-31. PubMed ID: 11694249
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The ninth component of complement and the pore-forming protein (perforin 1) from cytotoxic T cells: structural, immunological, and functional similarities.
    Young JD; Cohn ZA; Podack ER
    Science; 1986 Jul; 233(4760):184-90. PubMed ID: 2425429
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Resistance to the pore-forming protein of cytotoxic T cells: comparison of target cell membrane rigidity.
    Ojcius DM; Jiang SB; Persechini PM; Storch J; Young JD
    Mol Immunol; 1990 Sep; 27(9):839-45. PubMed ID: 2215476
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Structure, function and expression of murine and human perforin 1 (P1).
    Podack ER; Lowrey DM; Lichtenheld M; Olsen KJ; Aebischer T; Binder D; Rupp F; Hengartner H
    Immunol Rev; 1988 Mar; 103():203-11. PubMed ID: 3292394
    [No Abstract]   [Full Text] [Related]  

  • 28. The homologous restriction factor is immunologically related to complement components C8 and C9 and to lymphocyte pore-forming protein perforin through cysteine-rich domains.
    Young JD; Rosse WF; Hasselkus-Light CS
    Biochem Biophys Res Commun; 1990 Jan; 166(2):648-52. PubMed ID: 2302230
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Structural/functional similarity between proteins involved in complement- and cytotoxic T-lymphocyte-mediated cytolysis.
    Tschopp J; Masson D; Stanley KK
    Nature; 1986 Aug 28-Sep 3; 322(6082):831-4. PubMed ID: 2427956
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The molecular architecture of human complement component C6.
    DiScipio RG; Hugli TE
    J Biol Chem; 1989 Sep; 264(27):16197-206. PubMed ID: 2789218
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Cytotoxic molecules, perforin and serine esterase in cytotoxic T lymphocyte].
    Koizumi H
    Arerugi; 1989 Jan; 38(1):41-8. PubMed ID: 2787151
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Tumor-specific CTL kill murine renal cancer cells using both perforin and Fas ligand-mediated lysis in vitro, but cause tumor regression in vivo in the absence of perforin.
    Seki N; Brooks AD; Carter CR; Back TC; Parsoneault EM; Smyth MJ; Wiltrout RH; Sayers TJ
    J Immunol; 2002 Apr; 168(7):3484-92. PubMed ID: 11907109
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Structure and function of the murine perforin promoter and upstream region. Reciprocal gene activation or silencing in perforin positive and negative cells.
    Lichtenheld MG; Podack ER
    J Immunol; 1992 Oct; 149(8):2619-26. PubMed ID: 1401900
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Perforin and serine esterase gene expression in stimulated human T cells. Kinetics, mitogen requirements, and effects of cyclosporin A.
    Liu CC; Rafii S; Granelli-Piperno A; Trapani JA; Young JD
    J Exp Med; 1989 Dec; 170(6):2105-18. PubMed ID: 2584937
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Anti-idiotypic antibodies derived against C8, C9 and perforin bind homologous restriction factor.
    Young JD; Jiang S; Liu CC; Hasselkus-Light CS
    J Immunol Methods; 1990 Mar; 128(1):133-42. PubMed ID: 1691232
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Expression of lymphocyte perforin in the mouse uterus during pregnancy.
    Zheng LM; Liu CC; Ojcius DM; Young JD
    J Cell Sci; 1991 Jun; 99 ( Pt 2)():317-23. PubMed ID: 1885672
    [TBL] [Abstract][Full Text] [Related]  

  • 37. In vivo expression of perforin by CD8+ lymphocytes during an acute viral infection.
    Young LH; Klavinskis LS; Oldstone MB; Young JD
    J Exp Med; 1989 Jun; 169(6):2159-71. PubMed ID: 2471775
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Expression of human perforin in a mouse cytotoxic T lymphocyte cell line: evidence for perturbation of granule-mediated cytotoxicity.
    Thia KY; Smyth MJ; Trapani JA
    J Leukoc Biol; 1993 Dec; 54(6):528-33. PubMed ID: 8245705
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Perforin mRNA in primary peritoneal exudate cytotoxic T lymphocytes.
    Nagler-Anderson C; Lichtenheld M; Eisen HN; Podack ER
    J Immunol; 1989 Dec; 143(11):3440-3. PubMed ID: 2584700
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Purified perforin induces target cell lysis but not DNA fragmentation.
    Duke RC; Persechini PM; Chang S; Liu CC; Cohen JJ; Young JD
    J Exp Med; 1989 Oct; 170(4):1451-6. PubMed ID: 2794864
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.